New Study Examines ME/CFS Subgroups Based on Cerebrospinal Fluid and Blood-Plasma Proteins
Dr. Akiko Iwasaki, Sterling Professor of Immunology at Yale University and winner of the 2025 Solve Catalyst Award, recently published a study on distinguishing groups of people with ME/CFS based […]
Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that we’ve selected the Simmaron Research Institute as the winner of our second Solve ME/CFS Catalyst […]